not losing weight on semaglutide should i switch to tirzepatide Switching Semaglutide vs. Tirzepatide for weight

Your provider will guide you through the full process and expectations

Sudden onset of severe urinary frequency with lower abdominal pain : This may indicate acute cystitis or other bladder pathology

For residents of Princeton, Illinois seeking a breakthrough in obesity treatment, Klinic provides an accessible pathway to personalized healthcare right at your fingertips

Off-Label Use: Some medications are prescribed off-label for weight loss: Semaglutide (Ozempic): FDA-approved for type 2 diabetes (not weight loss) Identical to Wegovy but different indication Commonly prescribed off-label for weight loss Same effectiveness as Wegovy Tirzepatide (Mounjaro): FDA-approved for type 2 diabetes (not weight loss) Identical to Zepbound but different indication Prescribed off-label for weight loss before Zepbound approval Same effectiveness as Zepbound Metformin: Diabetes medication sometimes used for weight loss Produces only 1-3% weight loss Not FDA-approved for weight loss Generally not recommended as primary weight loss medication The Current State of Weight Loss Medication: Clear Winners: GLP-1 receptor agonists (especially tirzepatide and semaglutide) have become the gold standard for medical weight loss, producing results previously unattainable with medication alone